Drug name - Symproic

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
USRE46375 BDSI 6,7-unsaturated-7-carbamoyl substituted morphinan derivative
Oct, 2026

(4 years from now)

USRE46365 BDSI 6,7-unsaturated-7-carbamoyl substituted morphinan derivative
Jan, 2028

(5 years from now)

US9108975 BDSI Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same
Nov, 2031

(9 years from now)

US10952968 BDSI Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
May, 2033

(10 years from now)

CN101228172A BDSI 6,7-Unsaturated-7-Carbamoyl Substituted Morphinan Derivative
May, 2026

(3 years from now)

CN101228172B BDSI 6, 7-Unsaturated -7-Carbamoyl Substituted Morphinan Derivative.
May, 2026

(3 years from now)

CN103298819B BDSI 6, 7-Unsaturated -7 - Carbamoyl Morphinan Derivative Crystal And Preparation Method Thereof
Nov, 2031

(9 years from now)

CN105131003A BDSI Crystalline 6,7-Unsaturated-7-Carbamoyl Morphinane Derivative, And Method For Producing Same
Nov, 2031

(9 years from now)

CN105131003B BDSI 6, 7-Unsaturated -7 - Carbamoyl-Morphinan Derivative Crystal And Its Preparation Method
Nov, 2031

(9 years from now)

CN103298819A BDSI Crystalline 6,7-Unsaturated-7-Carbamoyl Morphinane Derivative, And Method For Producing Same
Nov, 2031

(9 years from now)

IN200705325P4 BDSI 6, 7-Unsaturated-7-Carbamoyl-Substituted Morphinan Derivative
May, 2026

(3 years from now)

IN264360B BDSI 6,7-Unsaturated-7-Carbamoyl-Substituted Morphinan Derivative
May, 2026

(3 years from now)

IN315783B BDSI Crystalline 6,7-Unsaturated-7-Carbamoyl Morphinane Derivative, And Method For Producing Same
Nov, 2031

(9 years from now)

EP1889848A1 BDSI 6,7-Unsaturated-7-Carbamoyl Substituted Morphinan Derivative
May, 2026

(3 years from now)

EP1889848B1 BDSI 6,7-Unsaturated-7-Carbamoyl Substituted Morphinan Derivative
May, 2026

(3 years from now)

EP1889848A4 BDSI 6,7-Unsaturated-7-Carbamoyl Substituted Morphinan Derivative
May, 2026

(3 years from now)

EP1889848B8 BDSI 6,7-Unsaturated-7-Carbamoyl Substituted Morphinan Derivative
May, 2026

(3 years from now)

EP3560929A2 BDSI Process For Preparing 6,7-Unsaturated-7-Carbamoyl Morphinane Derivative, And Intermediate
Nov, 2031

(9 years from now)

EP3560929A3 BDSI Crystalline 6,7-Unsaturated-7-Carbamoyl Morphinane Derivative, And Method For Producing Same
Nov, 2031

(9 years from now)

EP2639234B1 BDSI Crystalline 6,7-Unsaturated-7-Carbamoyl Morphinane Derivative, And Method For Producing Same
Nov, 2031

(9 years from now)

EP2639234A1 BDSI Crystalline 6,7-Unsaturated-7-Carbamoyl Morphinane Derivative, And Method For Producing Same
Nov, 2031

(9 years from now)

EP2639234A4 BDSI Crystalline 6,7-Unsaturated-7-Carbamoyl Morphinane Derivative, And Method For Producing Same
Nov, 2031

(9 years from now)

EP3560929B1 BDSI Process For Preparing 6,7-Unsaturated-7-Carbamoyl Morphinane Derivative, And Intermediate
Nov, 2031

(9 years from now)

EP2851075B1 BDSI Preparation Containing 6,7-Unsaturated-7-Carbamoylmorphinan Derivative
May, 2033

(10 years from now)

EP2851075A1 BDSI Preparation Containing 6,7-Unsaturated-7-Carbamoylmorphinan Derivative
May, 2033

(10 years from now)

EP2851075A4 BDSI Preparation Containing 6,7-Unsaturated-7-Carbamoylmorphinan Derivative
May, 2033

(10 years from now)

More Information on Dosage
Strength Dosage Availability
EQ 0.2MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.